In other words, V-9302 selectively blocks the uptake of glutamine by tumor cells but not by CD8 + T cells and promotes the synthesis of the cellular antioxidant glutathione, thereby improving the efferent function of CD8 + T cells [174]. The gene discussed is CD8A; the disease is neoplasm.